Stock Taper 
DYAI
$0.61
▼ DOWN 3.91% (-0.03)
KEY STATISTICS
Market Cap$22.38 M
52w High$1.60
52w Low$0.60
Dividend Yield—
Frequency—
P/E-2.67
Volume276.55K
Shares Out.36.44M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Mark A. Emalfarb
COMPENSATION 2026
Salary$612,398
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$26,891
Total$1,005,113
ABOUT
SECTOR
Healthcare
WENT PUBLIC
January 16, 2008
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
5
PRICE TARGET
Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00
UPCOMING EARNINGS
DateNov 11, 2026
DayWednesday
Rev. Est.$1.43M
NOV
11
WED
PRICE
$0.61 ▼ DOWN 3.91% (−$0.03)About Dyadic International, Inc.
https://www.dyadic.com ↗Dyadic International, Inc. is a biotech company leveraging its proprietary C1 platform to develop and produce enzymes, proteins, and vaccine candidates, including a COVID-19 vaccine, for human and animal health.
INDUSTRY
Biotechnology
A PRODUCT DYADIC INTERNATIONAL, INC. IS KNOWN FOR
AlbuFree™ DX
AlbuFree™ DX is a recombinant human albumin produced via Dyadic's fungal technology, launched with Proliant, aiming to generate recurring revenue and expand into cell culture applications.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Grant | $814.57K | $329.81K ▼ | $487.37K ▲ | $837.25K ▲ |
 | Research and Development | $350.05K | $220.72K ▼ | — | — |
 | License | — | $15K | $220K ▲ | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
15.71%
HOLDERS
53
TOP 12 OF 53 · RANKED BY POSITION SIZE
Apis Capital Advisors, LLC
Chapin Davis, Inc.
Vanguard Group Inc
Perkins Capital Management Inc
Truist Financial Corp
Geode Capital Management, LLC
Blackrock, Inc.
Ci Private Wealth, LLC
Northeast Financial Consultants Inc
Blackrock Inc.
Renaissance Technologies LLC
Landscape Capital Management, L.L.C.
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
10 PERCENT OWNER
Francisco Trust under agreement dated February 28, 1996
Sale · 38.0K shares
2026-07-22
★
10 PERCENT OWNER
Francisco Trust under agreement dated February 28, 1996
Sale · 54.8K shares
2026-07-23
★
10 PERCENT OWNER
Francisco Trust under agreement dated February 28, 1996
Sale · 2.6K shares
2026-07-24
★
10 PERCENT OWNER
Francisco Trust under agreement dated February 28, 1996
Sale · 15.0K shares
2025-01-07
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 PYPD | $5.07 | COMPARE |
 ATHE | $4.51 | COMPARE |
 RNXT | $1.67 | COMPARE |
 ANVS | $1.72 | COMPARE |
 CELU | $1.58 | COMPARE |
 VERU | $2.63 | COMPARE |
 ELUT | $0.88 | COMPARE |
 RVPH | $0.52 | COMPARE |